Skip to main content
SpringerLink
Log in

Hepatitis Viruses: Hepatitis B and Hepatitis D

Viral Infections of Humans

  • 40 Accesses

Abstract

Infection with hepatitis B virus (HBV) is the most common cause of chronic hepatitis and hepatocellular carcinoma in the world today despite the availability of an effective vaccine and antiviral therapies. The virus causes both acute and chronic infections. It is estimated 292 million in the world today are chronically infected with HBV. The epidemiology of this viral infection has revealed effective strategies for prevention and control that may lead to future reductions in the burden of disease, and even global elimination. Hepatitis D virus, also known as delta virus, is a defective virus that cannot establish or maintain infection except in the presence of HBV. While the global impact of HDV infection is less than that of HBV alone, its prevention and control represent unique challenges due to its unusual characteristics.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

Similar content being viewed by others

References

  • Abara WE, Qaseem A, Schillie S, McMahon B, Harris A, for the High Value Care Task Force of the American College of Physicians and the Centers for Disease Control and Prevention. Hepatitis B vaccination, screening, and linkage to care: best practice advice from the American College of Physicians and the Centers for Disease Control and Prevention. Ann Intern Med. 2017;167(11):794–804.

    Article  PubMed  Google Scholar 

  • Abbas Z, Jafri W, Raza S. Hepatitis D: scenario in the Asia-Pacific region. World J Gastroenterol. 2010;16:554–62.

    Article  PubMed  PubMed Central  Google Scholar 

  • Alavian S-M. Hepatitis D is a forgotten problem in hemodialysis patients in the world. Hepat Mon. 2008;8:1.

    Google Scholar 

  • Alter MJ. Epidemiology of hepatitis B in Europe and worldwide. J Hepatol. 2003;39:64–9.

    Article  Google Scholar 

  • Alter H, Block T, Brown N, Brownstein A, Brosgart C, Chang K-M, Chen P-J, Chisari F, Cohen C, et al. A research agenda for curing chronic hepatitis B virus infection. Hepatology. 2018;67(3):1127–31.

    Article  PubMed  Google Scholar 

  • Alvarado-Mora MV, Locarnini S, Rizzetto M, et al. An update on HDV: virology, pathogenesis and treatment. Antivir Ther. 2013;18:541–8.

    Article  PubMed  Google Scholar 

  • Andersson MI, Low N, Irish CJ, et al. Molecular epidemiology of a large community-based outbreak of hepatitis B in Bristol, UK. J Clin Virol. 2012;53:125–9.

    Article  PubMed  Google Scholar 

  • Arico S, Aragona M, Rizzetto M, et al. Clinical significance of antibody to the hepatitis delta virus in symptomless HBsAg carriers. Lancet. 1985;2:356–8.

    Article  CAS  PubMed  Google Scholar 

  • Bayer ME, Blumberg BS, Werner B. Particles associated with Australia antigen in the sera of patients with leukaemia, Down’s syndrome and hepatitis. Nature. 1968;218:1057–9.

    Article  CAS  PubMed  Google Scholar 

  • Beasley RP. Hepatitis B, virus. The major etiology of hepatocellular carcinoma. Cancer. 1988;61:1942–56.

    Article  CAS  PubMed  Google Scholar 

  • Beasley RP, Hwang LY, Lin CC, Chien CS. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22 707 men in Taiwan. Lancet. 1981a;2:1129–33.

    Article  CAS  PubMed  Google Scholar 

  • Beasley RP, Hwang LY, Lin CC, et al. Hepatitis B immune globulin (HBIG) efficacy in the interruption of perinatal transmission of hepatitis B virus carrier state. Initial report of a randomised double-blind placebo-controlled trial. Lancet. 1981b;2:388–93.

    Article  CAS  PubMed  Google Scholar 

  • Belongia EA, Costa J, Gareen IF, et al. NIH consensus development statement on management of hepatitis B. NIH Consens State Sci Statements. 2008;25:1–29.

    CAS  PubMed  Google Scholar 

  • Belongia EA, Costa J, Gareen IF, et al. NIH consensus development conference statement on management of hepatitis B. Ann Intern Med. 2009;150:104–10.

    Article  PubMed  Google Scholar 

  • Block TM, Gish R, Guo H, et al. Chronic hepatitis B: what should be the goal for new therapies? Antivir Res. 2013;98:27–34.

    Article  CAS  PubMed  Google Scholar 

  • Block T, Alter J, London WT, Bray M. A historical perspective on the discovery and elucidation of the hepatitis B virus. Antivir Res. 2016;131:109–23.

    Article  CAS  PubMed  Google Scholar 

  • Block T, Alter H, Brown N, Brownstein A, Brosgart C, Chang K-M, Chen P-J, Cohen C, et al. Research priorities for the discovery of a cure for chronic hepatitis B: report of a workshop. Antivir Res. 2017;150:93–100.

    Article  PubMed  Google Scholar 

  • Blumberg BS. Hepatitis B, virus, the vaccine, and the control of primary cancer of the liver. Proc Natl Acad Sci. 1997;94:7121–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Blumberg BS. Hepatitis B: the hunt for a killer virus. Princeton: Princeton University Press; 2002.

    Book  Google Scholar 

  • Blumberg BS, Millman I. U.S. Patent No. 3.636.191. Washington, DC: U.S. Patent and Trademark Office; 1972.

    Google Scholar 

  • Blumberg BS, Alter HJ, Visnich S. A “New” antigen in leukemia sera. JAMA. 1965;191:541–6.

    Article  CAS  PubMed  Google Scholar 

  • Blumberg BS, Gerstley BJ, Hungerford DA, London WT, Sutnick AI. A serum antigen (Australia antigen) in Down’s syndrome, leukemia, and hepatitis. Ann Intern Med. 1967;66:924–31.

    Article  CAS  PubMed  Google Scholar 

  • Blumberg BS, Sutnick AI, London WT. Hepatitis and leukemia: their relation to Australia antigen. Bull N Y Acad Med. 1968;44(12):1566–86.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Bonino F, Hoyer B, Shih J, Rizzetto M, Purcell R, Gerin J. Delta hepatitis agent: structural and antigenic properties of the delta-associated particle. Infect Immun. 1984;43:1000–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Brook M. Sexually acquired hepatitis. Sex Transm Infect. 2002;78:235–40.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Brooks GF, Butel JS, Morse SA. Jawetz, Melnick, & Adelberg’s medical microbiology. New York: McGraw-Hill Medical; 2007.

    Google Scholar 

  • Canese MG, Rizzetto M, Novara R, London WT, Purcell RH. Experimental infection of chimpanzees with the HBsAg-associated delta (δdL) agent: an ultrastructural study. J Med Virol. 1984;13:63–72.

    Article  CAS  PubMed  Google Scholar 

  • Carman WF, Karayiannis P, Waters J, et al. Vaccine-induced escape mutant of hepatitis B virus. Lancet. 1990;336:325–9.

    Article  CAS  PubMed  Google Scholar 

  • Casey JL. Hepatitis delta virus. Genetics and pathogenesis. Clin Lab Med. 1996;16:451–64.

    Article  CAS  PubMed  Google Scholar 

  • Castera L. Noninvasive methods to assess liver disease in patients with hepatitis B or C. Gastroenterology. 2012;142:1293–1302.e4.

    Article  PubMed  Google Scholar 

  • CDC. Recommendations for preventing transmission of infections among chronic hemodialysis patients. MMWR Recomm Rep. 2001;50:1–42.

    Google Scholar 

  • CDC. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the USA: recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunization of infants, children, and adolescents. MMWR Recomm Rep. 2005a;54:1–31.

    Google Scholar 

  • CDC. Guidelines for viral hepatitis surveillance and case management. Atlanta: Centers for Disease Control and Prevention, Division of Viral Hepatitis; 2005b. https://www.cdc.gov/hepatitis/statistics/surveillanceguidelines.htm. Accessed 1 Feb 2020.

  • CDC. Breastfeeding: diseases and conditions: hepatitis B and C infections. 2009. http://www.cdc.gov/breastfeeding/disease/hepatitis.htm. Accessed 1 Feb 2012.

  • CDC. The ABCs of hepatitis fact sheet. 2012a. http://www.cdc.gov/hepatitis/Resources/Professionals/PDFs/ABCTable.pdf. Accessed 1 Feb 2020.

  • CDC. Viral Hepatitis Surveillance – United States, 2010. 2012b. http://www.cdc.gov/hepatitis/Statistics/2010Surveillance/PDFs/2010HepSurveillanceRpt.pdf. Accessed 1 Dec 2012.

  • CDC. Epidemiology and prevention of vaccine-preventable diseases. 12th ed, 2nd printing ed. Washington, DC: Public Health Foundation; 2012c. p. 115–38.

    Google Scholar 

  • CDC. Healthcare-Associated Hepatitis B and C Outbreaks Reported to the Centers for Disease Control and Prevention (CDC) in 2008–2011. CDC, 2012d. http://www.cdc.gov/hepatitis/statistics/healthcareoutbreaktable.htm. Accessed 6 Feb 2019.

  • CDC. Viral Hepatitis Surveillance – United States, 2017. 2019. https://www.cdc.gov/hepatitis/statistics/2017surveillance/pdfs/2017HepSurveillanceRpt.pdf. Accessed 8 Feb 2020.

  • Chang MH. Hepatitis B virus infection. Semin Fetal Neonatal Med. 2007;12:160–7. Elsevier.

    Article  PubMed  Google Scholar 

  • Chang MH, You SL, Chen CJ, et al. Decreased incidence of hepatocellular carcinoma in hepatitis B vaccines: a 20-year follow-up study. JNCI. 2009;101(19):1348–55.

    Article  CAS  PubMed  Google Scholar 

  • Chen G, Lin W, Shen F, Iloeje UH, London WT, Evans AA. Past HBV viral load as predictor of mortality and morbidity from HCC and chronic liver disease in a prospective study. Am J Gastroenterol. 2006a;101:1797–803.

    Article  PubMed  Google Scholar 

  • Chen C, Yang H, Su J, et al. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA. 2006b;295:65–73.

    Article  CAS  PubMed  Google Scholar 

  • Chen C-H, Yang P-M, Huang G-T, Lee H-S, Sung J-L, Sheu J-C. Estimation of seroprevalence of hepatitis B virus and hepatitis C virus in Taiwan from a large-scale survey of free hepatitis screening participants. J Formos Med Assoc. 2007;106:148–55.

    Article  PubMed  Google Scholar 

  • Chen X, Chen J, Wen J, et al. Breastfeeding is not a risk factor for mother-to-child transmission of hepatitis B virus. PLoS One. 2013;8:e55303.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Chen X, Oidovsambuu O, Liu P, Grosely R, Elazar M, Winn VD, Fram B, Boa Z, Dai H, Dashtseren B, Yagaanbuyant D, Genden Z, Dashdorj N, Bungert A, Dashdorj N, Glenn JS. A novel quantitative microarray antibody capture assay identifies an extremely high hepatitis Delta virus prevalence among hepatitis B virus–infected Mongolians. Hepatology. 2017;66(6):1739–49.

    Article  CAS  PubMed  Google Scholar 

  • Ching LK, Gounder PP, Bulkow L, Spradling PR, Bruce MG, Negus S, Snowball M, McMahon BJ. Incidence of hepatocellular carcinoma according to hepatitis B virus genotype in Alaska Native people. Liver Int. 2016;36(10):1507–15.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Chu CJ, Lok ASF. Clinical significance of hepatitis B virus genotypes. Hepatology. 2003;35:1274–6.

    Article  Google Scholar 

  • Cohen C, Evans AA, London WT, Block J, Conti M, Block T. Underestimation of chronic hepatitis B virus infection in the United States of America. J Viral Hepat. 2008;15:12–3.

    CAS  PubMed  PubMed Central  Google Scholar 

  • Cohen C, Holmberg SD, McMahon BJ, et al. Is chronic hepatitis B being undertreated in the United States? J Viral Hepat. 2011;18:377–83.

    Article  CAS  PubMed  Google Scholar 

  • Cohen C, Caballero J, Martin M, Weerasinghe I, Ninde M, Block J. Eradication of hepatitis B: a nationwide community coalition approach to improving vaccination, screening, and linkage to care. J Community Health. 2013;38:799–804.

    Article  PubMed  Google Scholar 

  • Cooke, on behalf of The Lancet Gastroenterology & Hepatology Commissioners, et al. Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission. Lancet Gastroenterol Hepatol. 2019;4:135–84.

    Article  PubMed  Google Scholar 

  • Cooksley WG. Do we need to determine viral genotype in treating chronic hepatitis B? J Viral Hepat. 2010;17:601–10.

    CAS  PubMed  Google Scholar 

  • Covolo L, Pollicino T, Raimondo G, Donato F. Occult hepatitis B virus and the risk for chronic liver disease: a meta-analysis. Dig Liver Dis. 2013;45:238–44.

    Article  PubMed  Google Scholar 

  • Cross TJ, Rizzi P, Horner M, et al. The increasing prevalence of hepatitis delta virus (HDV) infection in South London. J Med Virol. 2008;80:277–82.

    Article  PubMed  Google Scholar 

  • Dane DS, Cameron CH, Briggs M. Virus-like particles in serum of patients with Australia-antigen-associated hepatitis. Lancet. 1970;1:695–8.

    Article  CAS  PubMed  Google Scholar 

  • Dunford L, Carr MJ, Dean J, et al. A multicentre molecular analysis of hepatitis B and blood-borne virus coinfections in Viet Nam. PLoS One. 2012;7:e39027.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • EASL. Clinical practice guidelines on the management of hepatitis B virus infection. European Association for the Study of the liver. J Hepatol. 2017;67:370–98.

    Google Scholar 

  • Evans AA, Fine M, London WT. Spontaneous seroconversion in hepatitis B e antigen-positive chronic hepatitis B: implications for interferon therapy. J Infect Dis. 1997;176:845–50.

    Article  CAS  PubMed  Google Scholar 

  • Evans AA, London WT, Gish RG, Cohen C, Block TM. Chronic HBV infection outside treatment guidelines: is treatment needed? Antivir Ther. 2012;18(2):229–35.

    Article  PubMed  Google Scholar 

  • Farci P. Delta hepatitis: an update. J Hepatol. 2003;39(Suppl 1):S212–9.

    Article  CAS  PubMed  Google Scholar 

  • Fattovich G, Giustina G, Christensen E, et al. Influence of hepatitis delta virus infection on morbidity and mortality in compensated cirrhosis type B. Gut. 2000;46:420–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Finelli L, Bell BP. Hepatitis B, Chapter 4. In: Roush SW, McIntyre L, Baldy LM, editors. Manual for the surveillance of vaccine-preventable diseases. 5th ed. Atlanta: Centers for Disease Control and Prevention; 2011.

    Google Scholar 

  • FitzSimons D, François G, Bonanni P, et al. Prevention of viral hepatitis in Italy. Vaccine. 2004;22:4092–6.

    Article  PubMed  Google Scholar 

  • Flodgren E, Bengtsson S, Knutsson M, et al. Recent high incidence of fulminant hepatitis in Samara, Russia: molecular analysis of prevailing hepatitis B and D virus strains. J Clin Microbiol. 2000;38:3311–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Freeman G. Epidemiology and incubation period of jaundice following yellow fever vaccination. Am J Trop Med Hyg. 1946;26:15–32.

    Article  CAS  PubMed  Google Scholar 

  • Froio N, Nicastri E, Comandini UV, et al. Contamination by hepatitis B and C viruses in the dialysis setting. Am J Kidney Dis. 2003;42:546–50.

    Article  PubMed  Google Scholar 

  • Gaeta GB, Stroffolini T, Smedile A, Niro G, Mele A. Hepatitis delta in Europe: vanishing or refreshing? Hepatology. 2007;46:1312–3.

    Article  PubMed  Google Scholar 

  • Ganem D, Prince AM. Hepatitis B virus infection – natural history and clinical consequences. N Engl J Med. 2004;350:1118–29.

    Article  CAS  PubMed  Google Scholar 

  • Gerlich WH, Glebe D, Schüttler CG. Deficiencies in the standardization and sensitivity of diagnostic tests for hepatitis B virus. J Viral Hepat. 2007;Suppl 1:16–21.

    Google Scholar 

  • Gish RG, Gadano AC. Chronic hepatitis B: current epidemiology in the Americas and implications for management. J Viral Hepat. 2006;13:787–98.

    Article  CAS  PubMed  Google Scholar 

  • Gish R, Hana D, Kane S, Clark M, Mangahas M, Sumbella B, Winters MA, Proudfoot J, Glenn JS. Coinfection with hepatitis B and D: epidemiology, prevalence and disease in patients in Northern California. J Gastroenterol Hepatol. 2013;28:1521–5.

    Article  PubMed  Google Scholar 

  • Guidotti LG, Chisari FV. Immunobiology and pathogenesis of viral hepatitis. Annu Rev Pathol Mech Dis. 2006;1:23–61.

    Article  CAS  Google Scholar 

  • Guilhot S, Huang S, Xia YP, La Monica N, Lai M, Chisari FV. Expression of the hepatitis delta virus large and small antigens in transgenic mice. J Virol. 1994;68:1052–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Han SH. Extrahepatic manifestations of chronic hepatitis B. Clin Liver Dis. 2004;8:403–18.

    Article  PubMed  Google Scholar 

  • Harris RA, Chen G, Lin W-Y, Shen FM, London WT, Evans AA. Spontaneous clearance of high-titer serum HBV DNA and risk of hepatocellular carcinoma in a Chinese population. Cancer Causes Control. 2003;14:995–1000.

    Article  PubMed  Google Scholar 

  • Harrison PM, Lau JY, Williams R. Hepatology. Postgrad Med J. 1991;67:719–41.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hauri AM, Armstrong GL, Hutin YJ. The global burden of disease attributable to contaminated injections given in health care settings. Int J STD AIDS. 2004;15:7–16.

    Article  PubMed  Google Scholar 

  • Heiberg IL, Hogh B. Horizontal transmission of hepatitis B virus – why discuss when we can vaccinate? J Infect Dis. 2012;206:464–5.

    Article  Google Scholar 

  • Hepatitis B Foundation. Drug Watch. https://www.hepb.org/treatment-and-management/drug-watch/. Accessed 5 Feb 2020.

  • Hepatitis B Foundation. Hepatitis Delta Connect Drug Watch. https://www.hepb.org/research-and-programs/hepdeltaconnect/drug-watch/. Accessed 4 Feb 2020.

  • Heymann DL, American Public Health Association. Control of communicable diseases manual. Washington, DC: American Public Health Association; 2004.

    Google Scholar 

  • Hill HA, Elam-Evans LD, Yankey D, Singleton JA, Kang Y. Vaccination coverage among children aged 19–35 months – United States, 2017. MMWR Wkly. 2018;67(40):1123–8.

    Article  Google Scholar 

  • Holmberg SD, Suryaprasad A, Ward JW. Updated CDC recommendations for the management of hepatitis B virus–infected health-care providers and students. MMWR Recomm Rep. 2012;16:1–10.

    Google Scholar 

  • Hoofnagle J. Serologic markers of hepatitis B virus infection. Annu Rev Med. 1981;32:1–11.

    Article  CAS  PubMed  Google Scholar 

  • Hoofnagle JH. Action plan for liver disease research. Hepatology. 2004;40:1240.

    Article  Google Scholar 

  • Hoofnagle JH, Shafritz DA, Popper H. Chronic type B hepatitis and the “healthy” HBsAg carrier state. Hepatology. 1987;7:758–63.

    Article  CAS  PubMed  Google Scholar 

  • Hosaka T, et al. Long-term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection. J Hepatol. 2013;58(1):98–107.

    Article  CAS  Google Scholar 

  • Hsu YS, Chien RN, Yeh CT, et al. Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B. Hepatology. 2002;35:1522–7.

    Article  PubMed  Google Scholar 

  • Hughes SA, Wedemeyer H, Harrison PM. Hepatitis delta virus. Lancet. 2011;378:73–85.

    Article  PubMed  Google Scholar 

  • Hui CK, Leung N, Yuen ST, et al. Natural history and disease progression in Chinese chronic hepatitis B patients in immune-tolerant phase. Hepatology. 2007;46:395–401.

    Article  PubMed  Google Scholar 

  • Huo TI, Wu JC, Wu SI, et al. Changing seroepidemiology of hepatitis B, C, and D virus infections in high-risk populations. J Med Virol. 2004;72:41–5.

    Article  PubMed  Google Scholar 

  • Hurie MB, Mast EE, Davis JP. Horizontal transmission of hepatitis B virus infection to United States-born children of Hmong refugees. Pediatrics. 1992;89:269–73.

    Article  CAS  PubMed  Google Scholar 

  • Hyams KC. Risks of chronicity following acute hepatitis B virus infection: a review. Clin Infect Dis. 1995;20:992–1000.

    Article  CAS  PubMed  Google Scholar 

  • IARC. Monographs on the evaluation of carcinogenic risk to humans. IARC Monogr. 1994;59:45–221.

    Google Scholar 

  • Inoue J. Factors involved in the development of fulminant hepatitis B: are the mutations of hepatitis B virus implicated? Hepatol Res. 2009;39:1053–5.

    Article  CAS  PubMed  Google Scholar 

  • James L, Fong C, Foong B, et al. Hepatitis B seroprevalence study 1999. Singap Med J. 2001;42:420–4.

    CAS  Google Scholar 

  • Ji J, Sundquist K, Sundquist J. A population-based study of hepatitis D virus as potential risk factor for hepatocellular carcinoma. J Natl Cancer Inst. 2012;104:790–2.

    Article  PubMed  Google Scholar 

  • Kao JH. Hepatitis B, viral genotypes: clinical relevance and molecular characteristics. J Gastroenterol Hepatol. 2002;17:643–50.

    Article  CAS  PubMed  Google Scholar 

  • Kao JH, Chen PJ, Lai MY, Chen DS. Hepatitis B virus genotypes and spontaneous hepatitis B e antigen seroconversion in Taiwanese hepatitis B carriers. J Med Virol. 2004;72:363–9.

    Article  CAS  PubMed  Google Scholar 

  • Kew MC, Kramvis A, Yu MC, Arakawa K, Hodkinson J. Increased hepatocarcinogenic potential of hepatitis B virus genotype A in Bantu-speaking sub-saharan Africans. J Med Virol. 2005;75:513–21.

    Article  CAS  PubMed  Google Scholar 

  • Khan AJ, Simard EP, Bower WA, et al. Ongoing transmission of hepatitis B virus infection among inmates at a state correctional facility. Am J Public Health. 2005;95:1793–9.

    Article  PubMed  PubMed Central  Google Scholar 

  • Kobayashi H, Tsuzuki M, Koshimizu K, et al. Susceptibility of hepatitis B virus to disinfectants or heat. J Clin Microbiol. 1984;20:214–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kowdley KV, Wang CC, Welch S, Roberts H, Brosgart CL. Prevalence of chronic hepatitis B among foreign-born persons living in the United States by country of origin. Hepatology. 2012;56(2):422–33.

    Article  PubMed  Google Scholar 

  • Koziel MJ. Cytokines in viral hepatitis. Semin Liver Dis. 1999;19:157–69.

    Article  CAS  PubMed  Google Scholar 

  • Kuo A, Gish R. Chronic hepatitis B infection. Clin Liver Dis. 2012;16:347–69.

    Article  PubMed  Google Scholar 

  • Le Gal F, Gault E, Ripault MP, et al. Eighth major clade for hepatitis delta virus. Emerg Infect Dis. 2006;12:1447–50.

    Article  PubMed  PubMed Central  Google Scholar 

  • Lehman EJ, Huy J, Levy E, Viet SM, Mobley A, McCleery TZ. Bloodborne pathogen risk reduction activities in the body piercing and tattooing industry. Am J Infect Control. 2010;38:130–8.

    Article  PubMed  Google Scholar 

  • Liang X, Bi S, Yang W, et al. Epidemiological serosurvey of hepatitis B in China – declining HBV prevalence due to hepatitis B vaccination. Vaccine. 2009;27:6550–7.

    Article  PubMed  Google Scholar 

  • Liaw YF. Clinical utility of hepatitis B surface antigen quantitation in patients with chronic hepatitis B: a review. Hepatology. 2011;53:2121–9.

    Article  CAS  PubMed  Google Scholar 

  • Lin CL, Kao JH. Hepatitis B viral factors and clinical outcomes of chronic hepatitis B. J Biomed Sci. 2008;15:137–45.

    Article  PubMed  Google Scholar 

  • Lin CL, Kao JH. The clinical implications of hepatitis B virus genotype: recent advances. J Gastroenterol Hepatol. 2011;26(Suppl 1):123–30.

    Article  PubMed  Google Scholar 

  • Lin CL, Kao JH. Hepatitis B virus genotypes and variants. Cold Spring Harb Perspect Med. 2015;5:a021436.

    Article  PubMed  PubMed Central  Google Scholar 

  • Lin Y-C, Chang M-H, Ni Y-H, Hsu H-Y, Chen D-S. Long-term immunogenicity and efficacy of universal hepatitis B virus vaccination in Taiwan. J Infect Dis. 2003;187:134–8.

    Article  PubMed  Google Scholar 

  • Livingston SE, Simonetti JP, Bulkow LR, et al. Clearance of hepatitis B e antigen in patients with chronic hepatitis B and genotypes A, B, C, D, and F. Gastroenterology. 2007;133:1452–7.

    Article  CAS  PubMed  Google Scholar 

  • Locarnini S. Molecular virology of hepatitis B virus. Semin Liver Dis. 2004;24:3–10.

    Article  CAS  PubMed  Google Scholar 

  • Lok AS. Hepatitis B, infection: pathogenesis and management. J Hepatol. 2000;32:89–97.

    Article  CAS  PubMed  Google Scholar 

  • Lok AS. Does antiviral therapy for hepatitis B and C prevent hepatocellular carcinoma? J Gastroenterol Hepatol. 2011;26:221–7.

    Article  PubMed  Google Scholar 

  • Lok AS, Lai CL, Wu PC, Leung EK, Lam TS. Spontaneous hepatitis B e antigen to antibody seroconversion and reversion in Chinese patients with chronic hepatitis B virus infection. Gastroenterology. 1987;92:1839–43.

    Article  CAS  PubMed  Google Scholar 

  • Lok AS, Wong A, Sporton S, Lai CL, Liu V, Chung HT. Hepatitis D virus superinfection remains a rare occurrence in non-drug abusers in Hong Kong. J Hepatol. 1992;14:332–4.

    Article  CAS  PubMed  Google Scholar 

  • London WT, Blumberg BS. Comments on the role of epidemiology in the investigation of hepatitis B virus. Epidemiol Rev. 1985;7:59–79.

    Article  CAS  PubMed  Google Scholar 

  • Lustbader ED, London WT, Blumberg BS. Study design for a hepatitis B vaccine trial. Proc Natl Acad Sci. 1976;73:955–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Makuwa M, Caron M, Souquière S, Malonga-Mouelet G, Mahé A, Kazanji M. Prevalence and genetic diversity of hepatitis B and delta viruses in pregnant women in Gabon: molecular evidence that hepatitis delta virus clade 8 originates from and is endemic in central Africa. J Clin Microbiol. 2008;46:754–6.

    Article  PubMed  Google Scholar 

  • Makuwa M, Mintsa-Ndong A, Souquiere S, Nkoghe D, Leroy EM, Kazanji M. Prevalence and molecular diversity of hepatitis B virus and hepatitis delta virus in urban and rural populations in northern Gabon in central Africa. J Clin Microbiol. 2009;47:2265–8.

    Article  PubMed  PubMed Central  Google Scholar 

  • Manos MM, Leyden WA, Murphy RC, Terrault NA, Bell BP. Limitations of conventionally derived chronic liver disease mortality rates: results of a comprehensive assessment. Hepatology. 2008;47:1150–7.

    Article  PubMed  Google Scholar 

  • Margolis HS, Alter MJ, Hadler SC. Hepatitis B: evolving epidemiology and implications for control. Semin Liver Dis. 1991;11:84–92.

    Article  CAS  PubMed  Google Scholar 

  • Martinson FE, Weigle KA, Mushahwar IK, Weber DJ, Royce R, Lemon SM. Seroepidemiological survey of hepatitis B and C virus infections in Ghanaian children. J Med Virol. 1998;48:278–83.

    Article  Google Scholar 

  • Mast EE, Alter MJ, Margolis HS. Strategies to prevent and control hepatitis B and C virus infections: a global perspective. Vaccine. 1999;17:1730–3.

    Article  CAS  PubMed  Google Scholar 

  • Mast EE, Margolis HS, Fiore AE, et al. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part 1: immunization of infants, children, and adolescents. MMWR Recomm Rep. 2005;54:1–31.

    PubMed  Google Scholar 

  • Mast EE, Weinbaum CM, Fiore AE, et al. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) part II: immunization of adults. MMWR Recomm Rep. 2006;55:1–33; quiz CE1–4.

    PubMed  Google Scholar 

  • McMahon BJ. Epidemiology and natural history of hepatitis B. Semin Liver Dis. New York: Thieme-Stratton; 2005. p. 3–8, c1981-.

    Google Scholar 

  • McMahon BJ. The natural history of chronic hepatitis B virus infection. Hepatology. 2009a;49:S45–55.

    Article  CAS  PubMed  Google Scholar 

  • McMahon BJ. The influence of hepatitis B virus genotype and subgenotype on the natural history of chronic hepatitis B. Hepatol Int. 2009b;(3):334–42.

    Google Scholar 

  • McMahon BJ, Alward WL, Hall DB, et al. Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state. J Infect Dis. 1985;151:599–603.

    Article  CAS  PubMed  Google Scholar 

  • McMahon BJ, Alberts SR, Wainwright RB, Bulkow L, Lanier AP. Hepatitis B-related sequelae. Prospective study in 1400 hepatitis B surface antigen-positive Alaska native carriers. Arch Intern Med. 1990;150:1051–4.

    Article  CAS  PubMed  Google Scholar 

  • McMahon BJ, Holck P, Bulkow L, Snowball M. Serologic and clinical outcomes of 1536 Alaska Natives chronically infected with hepatitis B virus. Ann Intern Med. 2001;135:759–68.

    Article  CAS  PubMed  Google Scholar 

  • McQuillan G, Coleman PJ, Kruszon-Moran D, Moyer LA, Lambert SB, Margolis HS. Prevalence of hepatitis B virus infection in the United States: the National Health and Nutrition Examination Surveys, 1976 through 1994. Am J Public Health. 1999;89:14–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Mele A, Mariano A, Tosti ME, et al. Acute hepatitis delta virus infection in Italy: incidence and risk factors after the introduction of the universal anti-hepatitis B vaccination campaign. Clin Infect Dis. 2007;44:e17–24.

    Article  PubMed  Google Scholar 

  • Niro GA, Casey JL, Gravinese E, et al. Intrafamilial transmission of hepatitis delta virus: molecular evidence. J Hepatol. 1999;30:564–9.

    Article  CAS  PubMed  Google Scholar 

  • Nishioka SA, Gyorkos TW. Tattoos as risk factors for transfusion-transmitted diseases. Int J Infect Dis. 2001;5:27–34.

    Article  PubMed  Google Scholar 

  • NNDSS Annual Report Writing Group. Australia’s notifiable disease status, 2012: Annual report of the National Notifiable Diseases Surveillance System. Commun Dis Intell Q Rep. 2015;39(1):E46–E136.

    Google Scholar 

  • Nowak MA, Bonhoeffer S, Hill AM, Boehme R, Thomas HC, McDade H. Viral dynamics in hepatitis B virus infection. Proc Natl Acad Sci. 1996;93:4398–402.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Papatheodoridis GV, Lampertico P, Manolakopoulos S, Lok A. Incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving nucleos(t)ide therapy: a systematic review. J Hepatol. 2010;53:348–56.

    Article  CAS  PubMed  Google Scholar 

  • Pascarella S, Negro F. Hepatitis D virus: an update. Liver Int. 2011;31:7–21.

    Article  CAS  PubMed  Google Scholar 

  • Perillo R. Hepatitis B, and D. In: Feldman M, Friedman LS, Brandt LJ, editors. Sleisenger and Fordtran’s gastrointestinal and liver disease-2 volume set: pathophysiology, diagnosis, management, expert consult. Philadelphia: Saunders Elsevier; 2010. p. 1287–312.

    Chapter  Google Scholar 

  • Petersen NJ, Barrett DH, Bond WW, et al. Hepatitis B surface antigen in saliva, impetiginous lesions, and the environment in two remote Alaskan villages. Appl Environ Microbiol. 1976;32:572–4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Petersen KM, Bulkow LR, McMahon BJ, et al. Duration of hepatitis B immunity in low risk children receiving hepatitis B vaccinations from birth. Pediatr Infect Dis J. 2004;23:650–5.

    Article  PubMed  Google Scholar 

  • Prince AM. An antigen detected in the blood during the incubation period of serum hepatitis. Proc Natl Acad Sci U S A. 1968;60:814–21.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Prince AM, Lee DH, Brotman B. Infectivity of blood from PCR-positive, HBsAg-negative, anti-HBs-positive cases of resolved hepatitis B infection. Transfusion (Paris). 2002;41:329–32.

    Article  Google Scholar 

  • Radjef N, Gordien E, Ivaniushina V, Gault E, Anais P, Drugan T, Trinchet JC, Roulot D, Tamby M, Milinkovitch MC, Deny P. Molecular phylogenetic analyses indicate a wide and ancient radiation of African hepatitis delta virus, suggesting a deltavirus genus of at least seven major clades. J Virol. 2004;78:2537–44.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Raimondo G, Caccamo G, Filomia R, Pollicino T. Occult HBV infection. Semin Immunopathol. 2013;35:39–52.

    Article  CAS  PubMed  Google Scholar 

  • Razavi-Shearer D, Gamkrelidze I, Nguyen MH, et al. Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study. The Lancet Gastroenterology and Hepatology. 2018;3(6):383–403.

    Google Scholar 

  • Rizzetto M, Ciancio A. Epidemiology of hepatitis D. Semin Liver Dis. 2012;32:211–9.

    Article  PubMed  Google Scholar 

  • Rizzetto M, Canese M, Arico S, et al. Immunofluorescence detection of new antigen-antibody system (delta/anti-delta) associated to hepatitis B virus in liver and in serum of HBsAg carriers. Gut. 1977;18:997–1003.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Rizzetto M, Canese MG, Purcell RH, London WT, David Sly L, Gerin JL. Experimental HBV and δ infections of chimpanzees: occurrence and significance of intrahepatic immune complexes of HBcAg and δ antigen. Hepatology. 1981;1:567–74.

    Article  CAS  PubMed  Google Scholar 

  • Rizzetto M, Ponzetto A, Forzani I. Epidemiology of hepatitis delta virus: overview. Prog Clin Biol Res. 1991;364:1–20.

    CAS  PubMed  Google Scholar 

  • Sagnelli E, Stroffolini T, Ascione A, et al. The epidemiology of hepatitis delta infection in Italy. Promoting Group. J Hepatol. 1992;15:211–5.

    Article  CAS  PubMed  Google Scholar 

  • Sagnelli E, Stroffolini T, Mele A, Imparato M, Almasio PL. Italian Hospitals’ Collaborating G. Chronic hepatitis B in Italy: new features of an old disease–approaching the universal prevalence of hepatitis B e antigen-negative cases and the eradication of hepatitis D infection. Clin Infect Dis. 2008;46:110–3.

    Article  PubMed  Google Scholar 

  • Salassa B, Daziano E, Bonino F, et al. Serological diagnosis of hepatitis B and delta virus (HBV/HDV) coinfection. J Hepatol. 1991;12:10–3.

    Article  CAS  PubMed  Google Scholar 

  • Samuel M, Doherty P, Bulterys M, Jenison S. Association between heroin use, needle sharing and tattoos received in prison with hepatitis B and C positivity among street-recruited injecting drug users in New Mexico, USA. Epidemiol Infect. 2001;127:475–84.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Sarin K, Kumar M, Lau GK, Abbas Z, Chan HLY, Chen CJ, Chen DS, Chen HL, Chen PJ, Chien RN, Dokmeci AK, Gane E, Hou GL, Jafri W, Jia J, Kim JH, Lai CL, Lee HC, Lim SG, Liu CJ, Locarnini S, Al Mahtab M, Mohamed R, Omata R, Park J, Piratvisuth T, Sharma BC, Sollano J, Wang FS, Wei L, Yuen MF, Zheng SS, Kao JH. Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update. Hepatol Int. 2016;10:1–98.

    Article  CAS  PubMed  Google Scholar 

  • Sasadeusz J, Grigg A, Hughes P, Lim S-L, Lucas M, McColl G, McLachlan SA, Peters MG, Shakel N, Slavin M, Sundararajan V, Thompson A, Doyle J, Rickard J, De Cruz P, Gish RG, Visvanathan K. Screening and prophylaxis to prevent hepatitis B reactivation: introduction and immunology. Clin Liver Dis. 2019;23:487–92.

    Article  PubMed  Google Scholar 

  • Schillie S, Harris A, Link-Gelles R, Romero J, Ward J, Nelson N. Recommendations of the advisory committee on immunization practices for use of a hepatitis B vaccine with a novel adjuvant. MMWR 2018;67(15):455–458.

    Google Scholar 

  • Schweitzer A, Horn J, Mikolajczyk RT, Krause G, Ott JJ. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet. 2015;386(10003):1546–55.

    Article  PubMed  Google Scholar 

  • Seeger C, Mason WS. Hepatitis B virus biology. Microbiol Mol Biol Rev. 2000;64:51–68.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Shao ZJ, Zhang L, Xu JQ, et al. Mother-to-infant transmission of hepatitis B virus: a Chinese experience. J Med Virol. 2011;83:791–5.

    Article  PubMed  Google Scholar 

  • Shepard CW, Simard EP, Finelli L, Fiore AE, Bell BP. Hepatitis B virus infection: epidemiology and vaccination. Epidemiol Rev. 2006;28:112–25.

    Article  PubMed  Google Scholar 

  • Shi Y, Wu YH, Wu W, Zhang WJ, Yang J, Chen Z. Association between occult hepatitis B infection and the risk of hepatocellular carcinoma: a meta-analysis. Liver Int. 2012;32:231–40.

    Article  PubMed  Google Scholar 

  • Smith JB, Blumberg BS. Viral hepatitis, post necrotic cirrhosis, and hepatocellular carcinoma. Lancet. 1969;294(7627):953.

    Article  Google Scholar 

  • Smith HM, Lau JYN, Davies SE, Daniels HM, Alexander GJM, Williams R. Significance of serum IgM anti-HBc in chronic hepatitis B virus infection. J Med Virol. 1992;36:16–20.

    Article  CAS  PubMed  Google Scholar 

  • Smith EA, Jacques-Carroll L, Walker TY, Sirotkin B, Murphy TV. The national perinatal hepatitis B prevention program, 1994–2008. Pediatrics. 2012;129:609–16.

    Article  PubMed  Google Scholar 

  • Soběslavský O. Prevalence of markers of hepatitis B virus infection in various countries: a HO collaborative study. Bull World Health Organ. 1980;58:621.

    PubMed  PubMed Central  Google Scholar 

  • Song J, Yang F, Wang S, Tikande S, Deng Y, Tang W, Cao G. Efficacy and safety of antiviral treatment on blocking the mother-to-child transmission of hepatitis B virus: a meta-analysis. J Viral Hepat. 2019;26(3):397–406.

    PubMed  Google Scholar 

  • Stevens CE, Beasley RP, Tsui J, Lee WC. Vertical transmission of hepatitis B antigen in Taiwan. N Engl J Med. 1975;292:771–4.

    Article  CAS  PubMed  Google Scholar 

  • Stevens CE, Neurath RA, Beasley RP, Szmuness W. HBeAg and anti-HBe detection by radioimmunoassay: correlation with vertical transmission of hepatitis B virus in Taiwan. J Med Virol. 1979;3:237–41.

    Article  CAS  PubMed  Google Scholar 

  • Stevens CE, Taylor PE, Tong MJ, et al. Yeast-recombinant hepatitis B vaccine. Efficacy with hepatitis B immune globulin in prevention of perinatal hepatitis B virus transmission. JAMA. 1987;257:2612–6.

    Article  CAS  PubMed  Google Scholar 

  • Sutnick AI, London WT, Gerstley BJS, Cronlund MM, Blumberg BS. Anicteric hepatitis associated with Australia antigen: occurrence in patients with Down’s syndrome. JAMA. 1968;205(10):670–4.

    Article  CAS  PubMed  Google Scholar 

  • Sutnick AI, London WT, Blumberg BS. Australia antigen: a genetic basis for chronic liver disease and hepatoma? Ann Intern Med. 1971;74(3):442–4.

    Article  Google Scholar 

  • Szmuness W, Stevens CE, Harley EJ, et al. Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States. N Engl J Med. 1980;303:833–41.

    Article  CAS  PubMed  Google Scholar 

  • Taylor JM. Hepatitis delta virus: cis and trans functions required for replication. Cell. 1990;61:371–3.

    Article  CAS  PubMed  Google Scholar 

  • Taylor JM. The structure and replication of hepatitis delta virus. Annu Rev Microbiol. 1992;46:253–76.

    Article  CAS  PubMed  Google Scholar 

  • Taylor JM. Replication of human hepatitis delta virus: influence of studies on subviral plant pathogens. Adv Virus Res. 1999;54:45–60.

    Article  CAS  PubMed  Google Scholar 

  • Taylor JM. Hepatitis delta virus. Virology. 2006;344:71–6.

    Article  CAS  PubMed  Google Scholar 

  • Teo C. Molecular epidemiology of hepatitis B in England and Wales. J Clin Virol. 2005;34:S13–4.

    Article  CAS  PubMed  Google Scholar 

  • Terrault NA, Lok ASF, McMahon BJ, et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology. 2018;67:1560–99.

    Article  PubMed  Google Scholar 

  • Thompson ND, Perz JF, Moorman AC, Holmberg SD. Nonhospital health care-associated hepatitis B and C virus transmission: United States, 1998–2008. Ann Intern Med. 2009;150:33.

    Article  PubMed  Google Scholar 

  • Trepo C, Guillevin L. Polyarteritis nodosa and extrahepatic manifestations of HBV infection: the case against autoimmune intervention in pathogenesis. J Autoimmun. 2001;16:269–74.

    Article  CAS  PubMed  Google Scholar 

  • Tu T, Budzinska MA, Shackel NA, Urban S. HBV DNA integration: molecular mechanisms and clinical implications. Viruses. 2017;9(4):75.

    Article  PubMed Central  Google Scholar 

  • Turner SB, Kunches LM, Gordon KF, Travers PH, Mueller NE. Occupational exposure to human immunodeficiency virus (HIV) and hepatitis B virus (HBV) among embalmers: a pilot seroprevalence study. Am J Public Health. 1989;79:1425–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Viral Hepatitis Prevention Board. Prevention and control of viral hepatitis in Greece: lessons learnt and the way forward. Viral Hepat. 2008;16:2. http://www.vhpb.org/files/html/Meetings_and_publications/Viral_Hepatitis_Newsletters/vhv16n2.pdf. Accessed 1 Feb 2008.

    Google Scholar 

  • Vivekanandan P, Singh OV. Molecular methods in the diagnosis and management of chronic hepatitis B. Expert Rev Mol Diagn. 2010;10:921–35.

    Article  CAS  PubMed  Google Scholar 

  • Wedemeyer H. Hepatitis D, revival. Liver Int. 2011;31:140–4.

    Article  PubMed  Google Scholar 

  • Wedemeyer H, Manns MP. Epidemiology, pathogenesis and management of hepatitis D: update and challenges ahead. Nat Rev Gastroenterol Hepatol. 2010;7:31–40.

    Article  PubMed  Google Scholar 

  • Wedemeyer H, Heidrich B, Manns MP. Hepatitis D virus infection – not a vanishing disease in Europe! Hepatology. 2007;45:1331–2.

    Article  PubMed  Google Scholar 

  • WHO. Introduction of hepatitis B vaccine into childhood immunization services: management guidelines, including information for health workers and parents. Geneva: World Health Organization; 2001a.

    Google Scholar 

  • WHO. Hepatitis delta WHO/CDS/CSR/NCS/2001.1. 2001b. http://www.who.int/csr/disease/hepatitis/whocdscsrncs20011/en/index.html. Accessed 1 Mar 2013.

  • WHO. Hepatitis B (WHO/CDS/CSR/LYO/2002.2: hepatitis B). 2002. http://www.who.int/csr/disease/hepatitis/whocdscsrlyo20022/en/index.html. Accessed 8 Feb 2020.

  • WHO. Global routine vaccination coverage, 2011. Wkly Epidemiol Rec. 2012a;87:432.

    Google Scholar 

  • WHO. Hepatitis B. Factsheet no. 204. Geneva: World Health Organization; 2012b. Accessed 8 Feb 2020.

    Google Scholar 

  • WHO. Data guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection. ISBN 978 92 4 154905 9 (NLM classification: WC 536). 2015. https://www.who.int/hiv/pub/hepatitis/hepatitis-b-guidelines/en/. Accessed 4 Jan 2020.

  • Williams WW, Lu PJ, O’Halloran A, Bridges CB, Kim DK, Pilishvili T, Hales CM, Markowitz LE. Vaccination coverage among adults, excluding influenza vaccination – United States, 2013. Morb Mortal Wkly Rep CDC Surveill Summ. 2015;64(4):95–102.

    Google Scholar 

  • Woodruff BA, Moyer LA, O’Rourke KM, Margolis HS. Blood exposure and the risk of hepatitis B virus infection in firefighters. J Occup Med. 1993;35:1048–54.

    CAS  PubMed  Google Scholar 

  • World Health Organization. Global hepatitis report 2017. Geneva: World Health Organization; 2017. License: CC BY-NC-SA 3.0 IGO.

    Google Scholar 

  • Yang G, Vyas GN. Immunodiagnosis of viral hepatitides A to E and non-A to -E. Clin Diagn Lab Immunol. 1996;3:247–56.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Yang HI, Sherman M, Su J, et al. Nomograms for risk of hepatocellular carcinoma in patients with chronic hepatitis B virus infection. J Clin Oncol. 2010;28:2437–44.

    Article  PubMed  Google Scholar 

  • Yonghao G, Jin C, Jun L, Pumei D, Ying Y, Xiuhong F, Yanyang Z, Wanshen G. An epidemiological serosurvey of hepatitis B virus shows evidence of declining prevalence due to hepatitis B vaccination in central China. Int J Infect Dis. 2015;40:75–80.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Public Health Research, Hepatitis B Foundation, Doylestown, PA, USA

    Chari Cohen & Timothy M. Block

  2. Department of Microbiology and Immunology, Baruch S. Blumberg Institute, Doylestown, PA, USA

    Chari Cohen & Timothy M. Block

  3. Department of Epidemiology and Biostatistics, Drexel University School of Public Health, Philadelphia, PA, USA

    Alison A. Evans

Authors
  1. Chari Cohen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Alison A. Evans
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Timothy M. Block
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Chari Cohen .

Editor information

Editors and Affiliations

  1. School of Public Health, Yale University, Washington, DC, USA

    Richard A. Kaslow

  2. Vagelos College of Physicians & Surgeons, Columbia University, New York, NY, USA

    Lawrence R. Stanberry

  3. School of Medicine & Grad School of Biom, The University of Texas Medical Branch a, Galveston, TX, USA

    James W. LeDuc

Section Editor information

  1. Departmant of Pediatrics, Columbia University College of Physicians and Surgeons, New York, New York, USA

    Lawrence R. Stanberry

Rights and permissions

Reprints and permissions

Copyright information

© 2022 Springer Science+Business Media, LLC, part of Springer Nature

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Cohen, C., Evans, A.A., Block, T.M. (2022). Hepatitis Viruses: Hepatitis B and Hepatitis D. In: Kaslow, R.A., Stanberry, L.R., LeDuc, J.W. (eds) Viral Infections of Humans. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-9544-8_32-1

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-9544-8_32-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4939-9544-8

  • Online ISBN: 978-1-4939-9544-8

  • eBook Packages: Springer Reference MedicineReference Module Medicine

Publish with us

Policies and ethics

Chapter history

  1. Latest

    Hepatitis Viruses: Hepatitis B and Hepatitis D
    Published:
    14 May 2023

    DOI: https://doi.org/10.1007/978-1-4939-9544-8_32-2

  2. Original

    Hepatitis Viruses: Hepatitis B and Hepatitis D
    Published:
    22 March 2022

    DOI: https://doi.org/10.1007/978-1-4939-9544-8_32-1

Search

Navigation